阿尔茨海默病
中国生物技术公司SciNeuro制药与瑞士制药巨头诺华周一宣布达成一项价值近17亿美元的合作协议，旨在开发治疗阿尔茨海默病的药物，该病影响全球约5500万人。 该协议授予诺华独家全球权利，开发和商业化SciNeuro的抗体候选物，以针对这种进行性脑部疾病。 SciNeuro的新型淀粉样蛋白β靶向抗体项目利用专有血脑屏障穿梭技术，帮助更多药物进入大脑发生阿尔茨海默病损伤的区域。
由 AI 报道
A new study suggests that older adults at risk of Alzheimer's disease can slow their cognitive decline by taking just 3000 steps a day. Researchers found that this level of activity reduces the buildup of harmful brain proteins and improves cognitive function over time. The findings highlight the potential benefits of regular, moderate exercise for brain health.